GLP-1 and B12 Levels: Deficiency Monitoring

    By Trimi Medical Team10 min read

    Vitamin B12 deficiency is a recognized concern during GLP-1 treatment. The medications' effects on gastric function can impair B12 absorption, and reduced food intake decreases dietary B12 sources. Since B12 deficiency can cause serious neurological symptoms if left untreated, monitoring and supplementation are essential parts of responsible GLP-1 care.

    Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for lab interpretation and supplementation guidance.

    B12 Reference Ranges

    • Normal: 200-900 pg/mL
    • Low-normal (may still be functionally deficient): 200-300 pg/mL
    • Deficient: Below 200 pg/mL
    • Optimal: 400-700 pg/mL

    Functional B12 deficiency can occur even with levels in the "normal" range (200-300 pg/mL). Methylmalonic acid (MMA) and homocysteine levels can help identify functional deficiency when B12 levels are borderline.

    How GLP-1 Affects B12

    • Slowed gastric emptying: B12 absorption requires intrinsic factor produced by stomach cells. GLP-1's effects on gastric function may impair this process
    • Reduced stomach acid: Adequate stomach acid is needed to release B12 from food proteins. GLP-1 may reduce acid secretion
    • Reduced food intake: Eating less means consuming less B12 from dietary sources (meat, dairy, eggs)
    • Metformin interaction: Patients taking both GLP-1 and metformin (common in diabetes) have compounded B12 absorption risk

    Symptoms of B12 Deficiency

    B12 deficiency symptoms can be subtle and progressive:

    • Early: Fatigue, weakness, lightheadedness
    • Moderate: Numbness or tingling in hands and feet, difficulty walking, memory problems
    • Severe: Megaloblastic anemia, neuropathy, cognitive impairment

    The neurological symptoms (numbness, tingling, cognitive changes) are the most concerning because they can become irreversible if B12 deficiency is not corrected. This is why proactive monitoring is important rather than waiting for symptoms.

    Prevention and Supplementation

    • All GLP-1 patients: Consider a daily B12 supplement of 1,000 mcg (methylcobalamin preferred)
    • Sublingual forms: Sublingual B12 dissolves under the tongue and bypasses digestive absorption issues
    • B12 injections: For patients with confirmed deficiency, B12 injections provide direct absorption
    • Dietary sources: When eating, prioritize B12-rich foods like meat, fish, eggs, and dairy

    Monitoring Schedule

    • Baseline: B12 level before starting GLP-1
    • 6 months: First recheck
    • Annually: Ongoing monitoring during treatment
    • As needed: If neurological symptoms develop

    High-Risk Groups

    Certain patients need more vigilant B12 monitoring:

    • Patients also taking metformin
    • Patients over age 50 (reduced intrinsic factor production)
    • Patients on proton pump inhibitors (PPIs)
    • Vegetarians and vegans (limited dietary B12 sources)
    • Patients with a history of GI surgery

    Getting Started

    B12 monitoring is part of comprehensive GLP-1 care at Trimi. Visit our treatment options page. Compounded semaglutide is $99/month and tirzepatide is $125/month.

    Frequently Asked Questions

    Should I take B12 supplements on GLP-1?

    Yes, most GLP-1 patients benefit from B12 supplementation. A daily 1,000 mcg methylcobalamin supplement is a reasonable precaution. Sublingual forms are preferred because they bypass potential absorption issues in the stomach.

    Does GLP-1 cause B12 deficiency?

    GLP-1 medications can contribute to B12 deficiency through reduced stomach acid, slowed gastric emptying, and decreased food intake. The risk is manageable with monitoring and supplementation.

    How quickly can B12 deficiency develop?

    The body stores B12 for 3-5 years, so clinically significant deficiency typically develops gradually over months to years of impaired absorption. However, patients starting GLP-1 with already low-normal B12 levels can become deficient more quickly.

    Is B12 the same as the B12 in energy drinks?

    B12 is the same vitamin, but the quality and dose vary. A dedicated B12 supplement (1,000 mcg methylcobalamin) is more reliable than the small amounts in energy drinks or standard multivitamins.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Arora Health's 50-state provider network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Sean Arora, MD via Arora Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Sean Arora, MD through Arora Health's 50-state provider network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: November 5, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Why vitamin D deficiency risk increases during GLP-1 treatment. Understand testing, supplementation guidelines, and how reduced caloric intake affects vitamin D status.

    Understanding iron and ferritin levels during GLP-1 treatment. Learn about anemia risk from reduced food intake, symptoms to watch for, and when supplementation is needed.

    How GLP-1 medications improve fasting insulin levels and insulin resistance. Learn about HOMA-IR, testing schedules, and tracking metabolic improvement during weight loss treatment.

    How GLP-1 medications affect cholesterol, triglycerides, and other lipid markers. Understand expected improvements, testing schedules, and the cardiovascular benefits of GLP-1 treatment.

    Start your GLP-1 journey — from $99/mo

    Get Started